Recombia unlocks the potential of microorganisms through advanced metabolic engineering. The company operates a joint bioengineering platform to develop industrial organisms using fermentation and sustainable bioprocesses. This capability delivers solutions for customers in sectors including natural products, proteins, enzymes, and biobased chemicals.
Funding
Funding not disclosed
Founders
Product
Problem
Many industries rely on inefficient and unsustainable chemical production methods. Traditional manufacturing processes often depend on non-renewable resources and generate significant waste, creating environmental and economic challenges.
Solution
Recombia Biosciences offers a metabolic engineering platform that optimizes microorganisms for the production of a variety of bio-based products. By leveraging advanced synthetic biology and genome editing techniques, Recombia enables the sustainable biomanufacturing of chemicals, materials, and ingredients. Their approach involves modifying the metabolic pathways of industrial organisms like yeast and bacteria to enhance the production of target molecules. Through a joint bioengineering platform with Lesaffre, Recombia delivers cost-effective, high-performance microbial strains for various industrial applications, including natural products, proteins and enzymes, biobased chemicals, and biofuels.
Target Audience
Recombia's primary customers include companies in the natural products, food, feed, biofuels, and bio-based chemical industries seeking sustainable and efficient biomanufacturing solutions.
Features
- Multiplex genome editing capabilities for rapid strain engineering
- Natural product pathway discovery for identifying novel compounds
- Integrated bioengineering ecosystem with Lesaffre for strain development and scale-up
- Metabolic engineering of yeast and bacteria to enhance production of target molecules
- "Find and replace" genetic engineering approach for precise and efficient genome modification